Epitranscriptomic regulation of HIV-1 full-length RNA packaging.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
28 02 2022
Historique:
accepted: 25 01 2022
revised: 17 01 2022
received: 13 03 2021
pubmed: 10 2 2022
medline: 16 4 2022
entrez: 9 2 2022
Statut: ppublish

Résumé

During retroviral replication, the full-length RNA serves both as mRNA and genomic RNA. However, the mechanisms by which the HIV-1 Gag protein selects the two RNA molecules that will be packaged into nascent virions remain poorly understood. Here, we demonstrate that deposition of N6-methyladenosine (m6A) regulates full-length RNA packaging. While m6A deposition by METTL3/METTL14 onto the full-length RNA was associated with increased Gag synthesis and reduced packaging, FTO-mediated demethylation promoted the incorporation of the full-length RNA into viral particles. Interestingly, HIV-1 Gag associates with the RNA demethylase FTO in the nucleus and contributes to full-length RNA demethylation. We further identified two highly conserved adenosines within the 5'-UTR that have a crucial functional role in m6A methylation and packaging of the full-length RNA. Together, our data propose a novel epitranscriptomic mechanism allowing the selection of the HIV-1 full-length RNA molecules that will be used as viral genomes.

Identifiants

pubmed: 35137199
pii: 6524254
doi: 10.1093/nar/gkac062
pmc: PMC8887480
doi:

Substances chimiques

5' Untranslated Regions 0
Gene Products, gag 0
RNA, Viral 0
Adenosine K72T3FS567

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2302-2318

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Retrovirology. 2010 Aug 05;7:64
pubmed: 20687923
Curr Protoc Bioinformatics. 2011 Jun;Chapter 2:Unit 2.14
pubmed: 21633945
Science. 2015 May 22;348(6237):917-21
pubmed: 25999508
Elife. 2016 Jul 02;5:
pubmed: 27371828
Front Microbiol. 2018 Mar 28;9:576
pubmed: 29643844
Nat Struct Mol Biol. 2004 Jul;11(7):672-5
pubmed: 15208690
Nucleic Acids Res. 2016 Sep 19;44(16):7922-34
pubmed: 27280976
Sci Rep. 2017 Jul 31;7(1):6902
pubmed: 28761163
Virology. 2006 Jan 20;344(2):391-400
pubmed: 16216294
J Biol Chem. 2004 Nov 12;279(46):48397-403
pubmed: 15355993
J Virol. 1974 Jul;14(1):152-61
pubmed: 4134468
J Virol. 2000 Dec;74(23):11413-7
pubmed: 11070043
FEBS Lett. 2018 Jun;592(12):2012-2022
pubmed: 29754392
Cold Spring Harb Perspect Med. 2012 Feb;2(2):a006916
pubmed: 22355797
Cell. 2014 Nov 20;159(5):1096-1109
pubmed: 25416948
Cell Host Microbe. 2016 Nov 9;20(5):654-665
pubmed: 27773535
Biochemistry. 2005 Jun 28;44(25):9058-66
pubmed: 15966729
RNA Biol. 2020 Apr;17(4):528-538
pubmed: 31918596
Science. 2020 Apr 24;368(6489):413-417
pubmed: 32327595
RNA. 2001 Jan;7(1):143-57
pubmed: 11214176
RNA. 2006 Apr;12(4):542-6
pubmed: 16489186
Nucleic Acids Res. 2011 Nov 1;39(20):8915-27
pubmed: 21791531
Nat Methods. 2014 Sep;11(9):959-65
pubmed: 25028896
Virology. 2014 Apr;454-455:362-70
pubmed: 24530126
Proc Natl Acad Sci U S A. 2020 Mar 17;117(11):6145-6155
pubmed: 32132202
J Virol. 2010 Jul;84(13):6598-604
pubmed: 20427541
Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13378-13383
pubmed: 27834211
Viruses. 2020 Nov 09;12(11):
pubmed: 33182496
Nucleic Acids Res. 2017 Jun 2;45(10):6051-6063
pubmed: 28334903
Sci Rep. 2015 Dec 03;5:17680
pubmed: 26631448
Cancer Cell. 2019 Apr 15;35(4):677-691.e10
pubmed: 30991027
Nucleic Acids Res. 2015 Jan;43(1):373-84
pubmed: 25452335
J Biol Chem. 2002 May 31;277(22):19967-75
pubmed: 11896057
J Virol. 2002 Apr;76(7):3089-94
pubmed: 11884533
Nucleic Acids Res. 2018 Nov 30;46(21):11539-11552
pubmed: 30239828
J Virol. 1992 Jan;66(1):150-9
pubmed: 1727477
Cell Host Microbe. 2016 May 11;19(5):675-85
pubmed: 27117054
Biochim Biophys Acta. 2016 May;1859(5):719-30
pubmed: 27012366
Nucleic Acids Res. 2016 Jun 2;44(10):e91
pubmed: 26896799
J Biol Chem. 2018 Aug 24;293(34):12992-13005
pubmed: 29976753
Nat Chem Biol. 2014 Feb;10(2):93-5
pubmed: 24316715
J Biol Chem. 2003 Mar 28;278(13):11601-11
pubmed: 12458192
mBio. 2020 Apr 7;11(2):
pubmed: 32265329
J Virol. 1997 May;71(5):3397-406
pubmed: 9094609
Nat Chem Biol. 2011 Oct 16;7(12):885-7
pubmed: 22002720
RNA Biol. 2021 May;18(5):745-758
pubmed: 33103564
Nat Microbiol. 2016 Feb 22;1:16011
pubmed: 27572442
PLoS Biol. 2008 Apr 29;6(4):e96
pubmed: 18447581
Mol Cell. 2013 Jan 10;49(1):18-29
pubmed: 23177736
Virus Res. 2013 Feb;171(2):304-18
pubmed: 23036987
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):13033-13038
pubmed: 27791166
Virology. 2016 May;492:204-12
pubmed: 26967976
Nucleic Acids Res. 2007;35(8):2695-704
pubmed: 17426127
J Virol. 2000 Sep;74(18):8307-15
pubmed: 10954529
Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):E201-8
pubmed: 26712001
Nucleic Acids Res. 2013 Jul;41(12):6286-99
pubmed: 23630313
RNA. 2018 Mar;24(3):262-267
pubmed: 29222117
Proc Natl Acad Sci U S A. 1976 Apr;73(4):1154-8
pubmed: 57617
Nature. 2009 Aug 6;460(7256):711-6
pubmed: 19661910
Viruses. 2016 Sep 10;8(9):
pubmed: 27626439
J Virol. 1997 May;71(5):3407-14
pubmed: 9094610
Nat Commun. 2014 Jul 02;5:4304
pubmed: 24986025

Auteurs

Camila Pereira-Montecinos (C)

Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
HIV/AIDS Workgroup (CHAIR), Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Daniela Toro-Ascuy (D)

Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
HIV/AIDS Workgroup (CHAIR), Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Catarina Ananías-Sáez (C)

Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
HIV/AIDS Workgroup (CHAIR), Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Aracelly Gaete-Argel (A)

Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
HIV/AIDS Workgroup (CHAIR), Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Cecilia Rojas-Fuentes (C)

Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
HIV/AIDS Workgroup (CHAIR), Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Sebastián Riquelme-Barrios (S)

Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
HIV/AIDS Workgroup (CHAIR), Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Bárbara Rojas-Araya (B)

Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
HIV/AIDS Workgroup (CHAIR), Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Francisco García-de-Gracia (F)

Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
HIV/AIDS Workgroup (CHAIR), Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Paulina Aguilera-Cortés (P)

Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
HIV/AIDS Workgroup (CHAIR), Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Jonás Chnaiderman (J)

Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Mónica L Acevedo (ML)

Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Fernando Valiente-Echeverría (F)

Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
HIV/AIDS Workgroup (CHAIR), Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Ricardo Soto-Rifo (R)

Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
HIV/AIDS Workgroup (CHAIR), Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Articles similaires

Glucose and glutamine drive hepatitis E virus replication.

Shaheen Khan, Suruchi Aggarwal, Pooja Bhatia et al.
1.00
Glutamine Virus Replication Hepatitis E virus Glucose Glycolysis
Triple Negative Breast Neoplasms Tumor Microenvironment Humans Prognosis Female

Reconciling founder variant multiplicity of HIV-1 infection with the rate of CD4

James Baxter, Ch Julián Villabona-Arenas, Robin N Thompson et al.
1.00
Humans HIV-1 HIV Infections CD4-Positive T-Lymphocytes CD4 Lymphocyte Count
RNA, Long Noncoding Humans Virus Latency Monocytes HIV-1

Classifications MeSH